In recurrent GBM, NRP1 is down-regulated, indicating that disruption of the balance between VEGF-A and TGFβ signaling is a mechanism that promotes anti-angiogenic resistance in GBM [119]. This evidence concerns the gene NRP1 and glioblastoma.